Contemporary Practice in Structural and Valvular Heart Disease

Description

A persistent gap exists between the practice of cardiology and the most current, evidence-based and guideline-recommended evaluation and management of patients with structural and valvular heart disease. In a time of rapidly changing information and ongoing research findings, the practicing physician has difficulty maintaining an up-to-date knowledge base and, therefore, competency in these areas. Consequently, the physician’s performance lacks state-of-the-art practices. This course addresses this gap by extensively reviewing structural and valvular heart disease through didactic lectures, panel discussions and case presentations that emphasize newer concepts of diagnosis, decision-making and therapy in these areas.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Identify most recent evidence-based treatment options for patients with structural and valvular heart disease
• Describe new transcatheter technologies for the treatment for patients with structural and valvular heart disease
• Recognize the most recent evidence and insights about structural and valvular heart disease

Target Audience

This course is targeted to primary care physicians, specialty physicians, nurses, nurse practitioners and physician ssistants. This course may also be of interest to physicians who practice in cardiology and vascular medicine, critical care and trauma, family medicine, geriatrics, internal medicine, thoracic surgery or cardiac surgery.

Course Directors

Jonathan Passeri, MD

Assistant Professor of Medicine, Harvard Medical School
Co-Director, Heart Valve Program, Massachusetts General Hospital
Director, Interventional Echocardiography

Igor F. Palacios, MD

Professor of Medicine, Harvard Medical School
Director of Interventional Cardiology Emeritus, Massachusetts General Hospital

Thoralf M. Sundt, MD

Edward D. Churchill Professor of Surgery, Harvard Medical School
Chief, Division of Cardiac Surgery
Director, Corrigan Minehan Heart Center, Massachusetts General Hospital

Friday, September 11, 2020

7:30 a.m. — 7:50 a.m. - Introduction
Jonathan Passeri, MD

7:50 a.m. — 8:30 a.m. - TAVR: History, Present State, and Future Perspectives
Ignacio Inglessis-Azuaje, MD

8:30 a.m. — 9:10 a.m. - TAVR in Intermediate & Low Surgical Risk Patients: Advantages, Limitation, & Areas of Uncertainty
Arminder Jassar, MD

9:10 a.m. — 9:50 a.m. - TAVR Versus SAVR: Thinking About Outcome and Cost-Effectiveness
Suzanne Baron, MD, MSc

9:20 a.m. — 9:50 a.m. - Venous Thomboembolism and Anticoagulation in Pregnancy
Annemarie Fogerty, MD

9:50 a.m. — 10:00 a.m. - Break 

10:00 a.m. — 10:40 a.m. - Aortic Regurgitation: Challenges in Assessment and Timing of Intervention
Judy Hung, MD

10:40 a.m. — 11:10 a.m. - Training the Cardiac Surgeon of the Future: How has TAVR Changed the Field of Cardiac Surgery?
Nathaniel Langer, MD

11:10 a.m. — 11:50 a.m. - Structural Valve Degeneratrion: Choosing Between Valve-in-Valve TAVR Versus Redo SAVE
Jeffrey Popma, MD

11:50 a.m. — 12:00 p.m. - Break 

12:00 p.m. — 12:50 p.m. - Igor F. Palacios Lectureship: Cardiogenic Shock
William O'Neill, MD, FACC, FSCAI
Lunch will be provided.

12:50 p.m. — 1:00 p.m. - Break

1:00 p.m. — 1:40 p.m. - Mitral Valve Surgery for Mitral Regurgitation
Serguei Melnitchouk, MD

1:40 p.m. — 2:10 p.m. - Present and Future Transcatheter Therapy of Mitral Regurgitation
Jonathan Passeri, MD

2:10 p.m. — 2:50 p.m. - Secondary Mitral Regurgitation: When is Intervention Beneficial?
Jacob Dal-Bianco, MD

2:50 p.m. — 3:05 p.m. - Break

3:05 p.m. — 3:45 p.m. - Future Frontiers: Transcatheter Electrosurgery
Rahuk Sakhuja, MD, MPP 

4:00 p.m. — 4:30 p.m. - Aortic and Mitral Valve Cases: Challenging Scenarios with Expert Panel Discussion
Serguei Melnitchouk, MD, Jonathan Passeri, MD, Rahul Sakhuja, MD, MPP

4:20 p.m. — 4:30 p.m. - Wrap-up

Saturday, September 12, 2020

7:30 a.m. — 8:00 a.m. - Tricuspid Regurgitation: Disease Burden and Clinical Impact
Dhaval Kolte, MBBS, PhD

8:00 a.m. — 8:30 a.m. - Surgical Considerations for Tricuspid Valve Disease
Thoralf Sundt, MD

8:30 a.m. — 9:00 a.m. - Transcatheter Therapies for Tricuspid Regurgitation
Sammy Elmariah, MD

9:00 a.m. — 9:15 a.m. - Break 

9:15 a.m. — 9:45 a.m. - Atrial Septal Defect: Timing of Intervention and Transcatheter Therapies
Rahul Sakhuja, MD, MPP

9:45 a.m. — 10:15 a.m. - Atrial Septal Defect: There's Still a Role for Surgery
Duke Cameron, MD

10:15 a.m. — 10:45 a.m. - Contemporary Assessment and Management of Patent Foramen Ovale
Evin Yucel, MD

10:45 a.m. — 11:00 a.m. - Break

11:00 a.m. — 11:30 a.m. - Pulmonic Valve Disease in the Congenital Patient: Assessment and Indications for Intervention
Ami Bhatt, MD

11:30 a.m. — 12:05 p.m. - Pulmonic Valve Disease in Congenital Patient: Surgical and Transcatheter Therapies
Guilherme Silva, MD

12:05 p.m. — 1:00 p.m. - Lunch Break

1:00 p.m. — 1:30 p.m. - Coarctation of the Aorta: Assessment and Indications for Intervention
Doreen DeFaria-Yeh, MD

1:30 p.m. — 2:00 p.m. - Surgical Management of Coarctation of the Aorta
Duke Cameron, MD

2:00 p.m. — 2:30 p.m. - Transcatheter Therapy for Coarctation of the Aorta
Ignacio Inglessis-Azuaje, MD

2:30 p.m. — 2:45 p.m. - Break

2:45 p.m. — 3:15 p.m. - Left Atrial Appendage Exclusion: Indications and Procedural Considerations
Kevin Heist, MD, PhD

3:15 p.m. — 3:45 p.m. - Pulmonary Vein Stenosis after Pulmonary Vein Isolation: Incidence, Assessment and Management
Stephan Danik, MD, MPH

3:45 p.m. — 4:20 p.m. - Tricuspid, Congenital and LAA Cases: Challenging Scenarios with Expert Panel Discussion
Ami Bhatt, MD, Duke Cameron, MD, Stephan Danik, MD, MPH, Doreen DeFaria-Yeh, MD, Sammy Elmariah, MD, and Kevin Heist, MD, PhD 

4:20 p.m. — 4:30 p.m. - Closing Remarks